Metraipolis › archive › dc_74c83863c552

Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors — Europe PMC PMID:41350408

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41350408
DOI
10.1038/s41598-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-07T21:40:58.182Z
SHA-256 of the archived text
ed7eb7055c3ddd4a49308e58bdc4465f6deca4c00e3519a586e11aeb5740d424
Stable URL of this page
https://metraipolis.com/documento/dc_74c83863c552

How to cite

Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors — Europe PMC PMID:41350408 — Europe PMC (en), https://europepmc.org/article/MED/41350408 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_74c83863c552 (Metraipolis archive dc_74c83863c552, sha256 ed7eb7055c3ddd4a49308e58bdc4465f6deca4c00e3519a586e11aeb5740d424)
BibTeX
@misc{dc74c83863c552,
  title = {Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors — Europe PMC PMID:41350408},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41350408},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_74c83863c552; sha256 ed7eb7055c3ddd4a49308e58bdc4465f6deca4c00e3519a586e11aeb5740d424},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41350408. Agents can read the archived copy with the MCP tool read_document.